In the United States from 2004 to 2022, overdose deaths from polysubstance use escalated sharply across all racial and ethnic groups, with disproportionate increases across non-Hispanic Black and Hispanic individuals, particularly in opioid-stimulant and opioid-only profiles.
Cadet et al. (Wed,) studied this question.